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Abstract
Background: Increased serum levels of angiotensin converting enzyme and lysozyme are considered as inflammatory
markers for diagnosis of sarcoidosis which is an autoimmune inflammatory disease. The purpose of this study is to
evaluate the significance of differences in serum angiotensin converting enzyme and lysozyme levels of patients with
ocular involvement of other autoimmune inflammatory and infectious diseases.
Methods: This is a prospective study involving patients with ankylosing spondylitis, behcet’s disease, presumed
sarcoidosis, presumed latent tuberculosis, presumed latent syphilis, and control group. The serum levels of angiotensin
converting enzyme and lysozyme were analyzed by enzyme-linked immunosorbent assay. Bonnferoni analysis was
used to assess pairwise comparisons between the groups.
Results: There was a significant increase in serum angiotensin converting enzyme level in patients with presumed
sarcoidosis compared to ankylosing spondylitis (p = 0.0001), behcet’s disease (p = 0.0001), presumed latent tuberculosis
(p = 0.0001), presumed latent syphilis (p = 0.0001), and control group (p = 0.0001). The increase in serum lysozyme level
was significant for patients with presumed sarcoidosis with respect to ankylosing spondylitis (p = 0.0001), behcet’s
disease, (p = 0.0001) presumed latent tuberculosis (p = 0.001), presumed latent syphilis (p = 0.033), and control
group (p = 0.0001).
Conclusion: Elevated serum angiotensin converting enzyme levels are significant for patients with presumed
sarcoidosis compared to ocular involvement of other autoimmune diseases such as behcet’s disease and ankylosing
spondylitis, and ocular involvement of infectious diseases such as presumed latent tuberculosis and presumed latent
syphilis. However, elevated serum lysozyme level might be also detected in ocular involvement of infectious diseases
such as presumed latent tuberculosis and presumed latent syphilis.
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Background
The renin angiotensin system (RAS) is an important
hormonal system which promotes inflammation through
the axis of angiotensin converting enzyme (ACE)-angioten-
sin peptides-distinct receptor subtypes [1]. Hyperactivation
of the RAS system has been disclosed to involve in inflam-
matory responses of the eye [2, 3]. Increased serum ACE
activity has been reported especially in uveitis associated
with sarcoidosis, and also infectious uveitis such as
recurrent toxoplasmic and toxocaral iridocyclitis and
choroioretinitis [4, 5]. Lysozyme is an enzyme that
hydrolyses glycosidic bonds, and it is revealed to de-
grade the peptidoglycans in the bacterial cell wall [6].
Muramidase activity of lysozyme has been shown to
limit the inflammation caused by rapidly degrading
peptidoglycans at the site of infection [7]. Elevated levels
of serum lysozyme have been reported in granulomatous
uveitis especially sarcoidosis and tuberculosis [8]. The pur-
pose of this study is to evaluate the significance of differ-
ences in serum ACE and lysozyme levels of patients with
ocular involvement of autoimmune diseases such as
HLAB27+ ankylosing spondylitis (AS), HLAB51+ behcet’s
disease (BD) and presumed sarcoidosis and ocular involve-
ment of infectious diseases such as QuantiFERON(®)-TB
Gold+ presumed latent tuberculosis (TB) and presumed
latent syphilis compared to control group by using pair-
wise comparisons between the groups.
Methods
Study patients
This is a prospective study involving 76 patients with
AS, 72 patients with BD, 31 patients with presumed
sarcoidosis, and 68 patients with presumed latent TB, 11
patients with presumed latent syphilis, and 22 control
subjects having refractive errors only. Institutional review
board/ethics committee approval was obtained from the
Dunya Goz Hospital Institutional Board (DGH-070)
Ankara, Turkey. This study adhered to the tenets of the
Declaration of Helsinki. The written informed consent
was obtained for all individuals who enrolled in this study.
The patients had ocular manifestations including acute or
chronic granulomatous or non-granulomatous iritis or iri-
docyclitis, intermediate, posterior or panuveitis, retinitis,
retinal vasculitis, choroiditis and papillitis. The uveitis was
not always granulomatous inside the the group of pre-
sumed ocular sarcoidosis. The international criteria for
the diagnosis of presumed ocular sarcoidosis and inter-
national study criteria for BD were used [9, 10]. Inclusion
criteria for all patients involve the presence of ocular signs
associated with a positive test for HLAB27 for patients
with AS, a positive test for HLAB51 for the patients with
BD, a negative tuberculin skin test in BCG-vaccinated
patients, positive findings on chest x-ray or chest CT or
abnormal results on whole body Gallium 67 scintigraphy
for the patients with presumed sarcoidosis, a positive test
for QuantiFERON(®)-TB Gold In-Tube (Cellestis limited,
Melbourne, Australia) and a positive tuberculin skin test
for the patients with presumed latent TB. Presumed latent
syphilis was diagnosed on the basis of negative serum
venereal disease research laboratory test (VDRL) and
rapid plasma reagin test, (RPR) positive serum fluorescent
treponemal antibody absorption (FTAABS) and microhe-
magglutination assay for Treponema pallidum, (MHA-
TP), negative cerebrospinal fluid (CSF) FTAABS, and
improvement in level of ocular inflammation after treat-
ment with specific therapy for syphilis [11]. The difference
in the levels of ACE in granulomatous and a non-
granulomatous groups were not compared. The con-
nection of increased serum lysozyme levels between
systemic diseases such as sarcoidosis was not studied.
The exclusion criteria for the patient and control
groups were using ACE inhibitors, systemic steroids,
immunosuppressive or immunomodulatory therapies.
Blood sampling
Blood samples were collected from the patients by using
a standard aseptic technique. Native blood was incu-
bated for 60 min at room temperature; serum fractions
(separated by centrifugation at 1500 g for 15 min) were
stored at −20 °C.
Serum ACE activity measurement using
spectrophotometric assay
Serum ACE activity was measured as described by
Beneteau et al [12]. ACE activity was determined with
an artificial substrate (FAPGG, (N-[3-(2-furyl) acry-
loyl]-L-phenylalanyl-glycylglycine; Sigma-Aldrich) in a
reaction mixture containing 25 mM HEPES (N-2-hydro-
xyethylpiperazine-N-2-ethanesulfonic acid), 0.5 mM FAPGG,
300 mM NaCl, and the desired dilution of serum at pH 8.2.
Measurements were performed in 96-well plates
(Greiner-Bio One) at 37 °C. Changes in optical density
(340 nm) were measured at 5-min intervals for at least
90 min with a plate reader (NovoStar plate reader;
BMG Labtech). Optical density values were plotted as
a function of reaction time and fitted by linear regres-
sion (GraphPad Prism 5.0). The fit and the data were
accepted when r2 was >0.90. ACE activity was calcu-
lated with the equation:
activity ¼ S=kð ÞD
where S is the rate of observed decrease in optical density
(1/min), k is the change in optical density upon the
complete cleavage of 1 μmol of FAPGG, and D is the dilu-
tion of the serum. ACE activity is given in units where 1 U
is equivalent to the cleavage of 1 μmol of FAPGG in 1 min.
The reference range for serum ACE level was between 8
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and 52 U/L for adults, and between 13 and 100 U/L for
children less than 18 years of age.
Serum lysozyme activity measurement using radial
immunodiffusion
Serum lysozyme activity was measured by using radial
immunodiffusion as described by Mancini G. et al. [13].
Human ‘NL’ Nanorid plate, No GT073.3, (Binding Site
Ltd., Birmingham, UK) and lysozyme - NL 2.1–21*
GT073.3 NANORID™ kits (Binding Site Ltd., Birming-
ham, UK) were used. The precipitation ring diameters
were measured using Digital Rid Plate Reader. (Binding
Site Ltd., Birmingham, UK) The reference range for
serum lysozyme was between 9.6 and 16.8 mg/L for all
age groups.
Statistical analysis
Statistical analysis was performed by using SPSS for
Windows 13.0.1 (SPSS Inc., Chicago, IL, USA) statis-
tical software products. All results were expressed as
mean ± SD. All statistical analyses were performed
two-tailed and p < 0.05 was considered as significant.
One-way ANOVA and Tukey’s tests were used for age
distribution, and Chi Square test is used for sex distri-
bution. Multivariate analysis of covariance was used to
determine the significance of differences in serum
levels of ACE and lysozyme with age as the covariate.
Bonnferoni analysis was used to assess pairwise compari-
sons between the groups.
Results
Demographics of the patient and control groups
The age range, mean, standard deviation (SD), and the
lower and upper bounds of 95 % confidence interval
(CI) values for mean values of age for patients with AS,
BD, presumed sarcoidosis, presumed latent TB, pre-
sumed latent syphilis, and control group were shown in
Table 1. The age range of total 280 subjects was between
9 and 86 with a mean (SD) of 42.892 (16.013). The mean
(SD) ages of patients with AS, BD, presumed sarcoidosis,
presumed latent TB, presumed latent syphilis and con-
trol group were 41.868 (12.536), 38.277 (14.681), 41.000
(18.954), 52.735 (15.525), 44.272 (14.553), and 33.090
(15.377) years respectively (Table 1). The sex distribution
and percentages within the groups were shown in
Table 2. The total of 280 subjects 139 (49.6 %) were
female and 141 (50.4 %) were male. The sex distribution
and percentages of the patients with AS, BD, presumed
sarcoidosis, presumed latent TB, presumed latent syph-
ilis, and control group were 35 (46.10 %) female and 41
(53.9) male, 43 (59.7 %) female and 29 (40.3 %) male, 13
(41.9 %) female and 18 (58.1 %) male, 36 (52.9 %) female
and 32 (47.1 %) male, 4 (36.4 %) female and 7 (63.6 %)
male, and 8 (36.4 %) female and 14 (63.6 %) male
respectively (Table 2).
Serum ACE and lysozyme activities of the patient and
control groups
The mean (SD) values of serum ACE and lysozyme
levels of the patients with AS, BD, presumed sarcoidosis,
presumed latent TB, presumed latent syphilis and con-
trol group were shown in Table 3. The mean (SD) values
of serum ACE for patients with AS, BD, presumed sar-
coidosis, presumed latent TB, presumed latent syphilis
and control group were 29.363 (2.012), 31.227 (15.225),
58.164 (35.110), 33.061 (15.065), 30.527 (16.016) and
20.704 (7.962) U/L respectively (Table 3). The estimated
marginal means of serum ACE levels in groups were
disclosed in Fig. 1. According to this graph, the lowest
value for the estimated marginal mean of serum ACE
level is 21.251 U/L for control group, and the highest
value is 58.274 U/L for the patients with presumed
sarcoidosis. The estimated marginal mean values of
serum ACE level for the patients with AS, BD, presumed
latent TB and presumed latent syphilis were 29.360,
31.392, 32.500 and 30.452 U/L respectively which were
lower than the estimated marginal mean value of ACE
for presumed sarcoidosis, but higher than the estimated
Table 1 The sample size, age range, mean value, standard deviation, the lower and upper bounds of 95 % confidence interval for
mean age of the patients with ocular involvement of ankylosing spondylitis, behcet’s disease, presumed sarcoidosis, presumed latent
tuberculosis, presumed latent syphilis and control group
Groups n Min age Max age Mean age SD 95 % CI for Mean Lower Bound 95 % CI for Mean Upper Bound
AS 76 15 74 41.868 12.536 37.003 44.733
BD 72 9 75 38.277 14.681 34.827 41.727
P. Sarcoidosis 31 10 72 41.000 18.954 34.047 47.952
TB 68 21 86 52.735 15.525 48.977 56.493
P. Syphilis 11 22 67 44.272 14.553 34.495 54.050
Control 22 12 68 33.090 15.377 26.272 39.908
Total 280 9 86 42.892 16.013 41.009 44.776
n Sample size, Min minimum, Max maximum, SD standard deviation, CI confidence interval, AS ankylosing spondylitis, BD behcet’s disease, TB presumed latent
tuberculosis, P. Sarcoidosis presumed sarcoidosis, P. Syphilis presumed latent syphilis
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marginal mean value of ACE for control group (Fig. 1).
The mean (SD) values of serum lysozyme level for
patients with AS, BD, presumed sarcoidosis, presumed
latent TB, presumed latent syphilis and control group
were 14.096 (4.586), 14.244 (5.358), 20.712 (6.780),
15.259 (8.516), 14.018 (6.679) and 12.927 (4.720) mg/L
respectively (Table 3). The estimated marginal means of
serum lysozyme levels in groups were disclosed in Fig. 2.
According to this graph, the lowest value for the estimated
marginal mean of serum lysozyme level was13.200 mg/L
for control group, and the highest value was 20.776 mg/L
for patients with presumed sarcoidosis. The estimated
means of serum lysozyme levels of patients with AS, BD,
presumed latent TB and presumed latent syphilis were
14.122, 14.374, 14.998 and 13.989 mg/L respectively which
were lower than the estimated marginal mean value of
lysozyme for presumed sarcoidosis, and higher than the
estimated marginal mean value of serum lysozyme for
control group (Fig. 2).
Pairwise comparisons of the mean differences of serum
ACE levels between groups
The mean (SD) differences of serum ACE levels between
the patients with presumed sarcoidosis and AS, BD, pre-
sumed latent TB, presumed latent syphilis and control
group were 28.907 (3.735), 26.784 (3.770), 25.776 (3.898),
27.821 (6.155), and 37.016 (4.918) U/L respectively. (Table 4)
The increase in serum ACE level was significant for pa-
tients with presumed sarcoidosis compared to patients with
AS (p = 0.0001), BD (p = 0.0001), presumed latent TB (p =
0.0001), presumed latent syphilis (p = 0.0001), and control
group (p = 0.0001). The mean (SD) differences of serum
ACE levels between control group and AS, BD, pre-
sumed latent TB, presumed latent syphilis were −8.110
(4.288), −10.232 (4.285), −11.250 (4.528), and −9.195
(6.520) respectively (Table 4). There were no significant
differences of serum ACE levels between control group
and AS (p = 0.895), control group and BD (p = 0.264),
control group and TB, (p = 0.204) control group and
presumed latent syphilis. (p = 1.000) (Table 4) Pairwise
comparison of mean (SD) difference of serum ACE
level between AS and BD was −2.123 (2.894), between
AS and presumed latent TB was −3.141 (3.038), between
AS and presumed latent syphilis was −1.086 (5.656),
between BD and presumed latent TB was −1.018 (3.149),
between BD and presumed latent syphilis was 1.037
(5.689), and between presumed latent TB and presumed
latent syphilis was 2.055 (5.734) respectively (Table 4). No
significant differences of serum ACE levels revealed be-
tween AS and BD (p = 0.689), between AS and presumed
latent TB (p = 1.000), between AS and presumed latent
syphilis (p = 0.996), between BD and presumed latent TB
(p = 1.000), between BD and presumed latent syphilis (p =
0.817), and between presumed latent TB and presumed
latent syphilis (p = 0.504), (Table 4).
Pairwise comparisons of the mean differences of serum
lysozyme levels between groups
The mean (SD) differences of serum lysozyme levels
between patients with presumed sarcoidosis and AS, BD,
presumed latent TB, presumed latent syphilis and
control group were 6.641 (1.334), 6.394 (1.346), 5.778
(1.392), 6.785 (2.198), and 7.568 (1.756) mg/L respectively
(Table 5). The increase in serum lysozyme level was
Table 2 The sex distribution and sample size of patients with
ocular involvement of ankylosing spondylitis, behcet’s disease,
presumed sarcoidosis and presumed latent tuberculosis,
presumed latent syphilis and control group
Groups Female Male n
AS 35 (46.1 %) 41 (53.9 %) 76
BD 43 (59.7 %) 29 (40.3 %) 72
P. Sarcoidosis 13 (41.9 %) 18 (58.1 %) 31
TB 36 (52.9 %) 32 (47.1 %) 68
P. Syphilis 4 (36.4 %) 7 (63.6 %) 11
Control 8 (36.4 %) 14 (63.6 %) 22
Total 139 (49.6) 141 (50.4) 280
n sample size, AS ankylosing spondylitis, BD behcet’s disease, TB presumed
latent tuberculosis, P. Sarcoidosis presumed sarcoidosis, P. Syphilis presumed
latent syphilis
Table 3 The sample size, mean value, standard deviation of
serum angiotensin converting enzyme levels of the patients
with ocular involvement of ankylosing spondylitis, behcet’s
disease, presumed sarcoidosis, presumed latent tuberculosis,
presumed latent syphilis and control group
Groups Mean
value




Serum ACE Level (U/L)
AS 29.363 2.012 25.403 33.324
BD 31.486 2.091 27.369 35.603
P. Sarcoidosis 58.270 3.151 52.067 64.472
TB 32.504 2.254 28.066 36.942
P. Syphilis 30.449 5.285 20.044 40.854
Control 21.254 3.800 13.772 28.736
Serum Lysozyme Level
(mg/L)
AS 14.124 0.718 12.710 15.538
BD 14.371 0.747 12.901 15.841
P. Sarcoidosis 20.765 1.125 18.550 22.979
TB 14.987 0.805 13.402 16.571
P. Syphilis 13.980 1.887 10.265 17.695
Control 13.196 1.357 10.525 15.868
ACE angiotensin converting enzyme, AS ankylosing spondylitis, BD behcet’s
disease, CI confidence interval, TB presumed latent tuberculosis, P. Sarcoidosis
presumed sarcoidosis, P. Syphilis presumed latent syphilis, SD standard
deviation
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significant for patients with presumed sarcoidosis with
respect to AS (p = 0.0001), BD (p = 0.0001), presumed
latent TB (p = 0.001), presumed latent syphilis (p = 0.033),
and control group (p = 0.0001) (Table 5) The mean (SD)
differences of serum lysozyme levels between control
group and AS, BD, presumed latent TB, presumed latent
syphilis were −0.928 (1.531), −1.175 (1.530), −1.790
(1.617), and −0.784 (2.328) respectively (Table 5). There
were no significant differences of serum lysozyme levels
between control group and AS (p = 1.000), control group
and BD (p = 1.000) control group and presumed latent TB
(p = 1.000), control group and presumed latent syphilis
Fig. 1 The estimated marginal means of serum angiotensin converting enzyme levels of patients with ocular involvement of ankylosing
spondylitis, behcet’s disease, presumed sarcoidosis, presumed latent tuberculosis, presumed latent syphilis and control group
Fig. 2 The estimated marginal means of serum lysozyme levels of patients with ocular involvement of ankylosing spondylitis, behcet’s disease,
presumed sarcoidosis, presumed latent tuberculosis, presumed latent syphilis and control group
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(p = 1.000) (Table 5). Pairwise comparison of mean (SD)
difference of serum lysozyme level between AS and BD
was −0.247 (1.033), between AS and presumed latent
TB was −0.863 (1.085), between AS and presumed
latent syphilis was 0.144 (2.020), between BD and pre-
sumed latent TB was −0.616 (1.124), between BD and
presumed latent syphilis was 0.391 (2.031), and between
presumed latent TB and presumed latent syphilis was
1.007 (2.047) (Table 5). There were no significant differ-
ences of serum lysozyme levels between AS and BD (p =
1.000), between AS and presumed latent TB (p = 1.000),
between AS and presumed latent syphilis (p = 1.000), be-
tween BD and presumed latent TB (p = 1.000), between
BD and presumed latent syphilis (p = 1.000), and between
presumed latent TB and presumed latent syphilis (p =
1.000) (Table 5).
Discussion
Previous studies have demonstrated the correlations of
serum levels of inflammatory chemokines and cytokines
with serum ACE and lysozyme activities in patients with
ocular and pulmonary sarcoidosis [14, 15]. Chemokine
(C-X-C motif ) ligand 9 (CXCL9), also known as mono-
kine induced by gamma interferon, (MIG) and C-X-C
motif chemokine 10 (CXCL10) also known as interferon
gamma-induced protein 10 (IP-10) have been reported
Table 4 Pairwise comparison of the mean difference values of serum angiotensin converting enzyme levels of the patients with
ocular involvement of ankylosing spondylitis, behcet’s disease, presumed sarcoidosis, presumed latent tuberculosis, presumed latent
syphilis and control group
Pairwise Comparison Mean Difference Standard Deviation Sigb 95 % CI Lower Bound 95 % CI Upper Bound
AS - BD −2.123 2.894 0.689 −10.691 6.446
AS - P. Sarcoidosis −28.907 3.735 0.0001 −39.969 −17.845
AS - TB −3.141 3.038 1.000 −12.137 5.856
AS - P. Syphilis −1.086 5.656 0.996 −17.836 15.665
AS - Control 8.110 4.288 0.895 −4.590 20.809
BD - AS 2.123 2.894 0.689 −6.446 10.691
BD – P. Sarcoidosis −26.784 3.770 0.0001 −37.948 −15.620
BD - TB −1.018 3.149 1.000 −10.343 8.306
BD - P. Syphilis 1.037 5.689 0.817 −15.812 17.885
BD - Control 10.232 4.285 0.264 −2.458 22.922
P. Sarcoidosis - AS 28.907 3.735 0.0001 17.845 39.969
P. Sarcoidosis - BD 26.784 3.770 0.0001 15.620 37.948
P. Sarcoidosis - TB 25.766 3.898 0.0001 14.222 37.310
P. Sarcoidosis–P. Syphilis 27.821 6.155 0.0001 9.593 46.048
P. Sarcoidosis–Control 37.016 4.918 0.0001 22.453 51.580
TB - AS 3.141 3.038 1.000 −5.856 12.137
TB - BD 1.018 3.149 1.000 −8.306 10.343
TB - P. Sarcoidosis −25.766 3.898 0.0001 −37.310 14.222
TB - P. Syphilis 2.055 5.734 0.504 −14.925 19.095
TB - Control 11.250 4.528 0.204 −2.159 24.660
P. Syphilis - AS 1.086 5.656 0.996 −6.124 5.837
P. Syphilis - BD −1.037 5.689 0.817 −17.885 15.812
P. Syphilis–P. Sarcoidosis −27.821 6.155 1.000 −19.035 14.925
P. Syphilis - Control 9.195 6.520 1.000 −10.113 28.504
Control - AS −8.110 4.288 0.895 −20.809 4.590
Control - BD −10.232 4.285 0.264 −22.922 2.458
Control –P. Sarcoidosis −37.016 4.918 0.0001 −51.580 −22.453
Control - TB −11.250 4.528 0.204 24.660 2.159
Control - P. Syphilis −9.195 6.520 1.000 −28.504 10.113
The mean difference is significant at the 0.05 level
Sigb Adjustment for multiple comparisons Bonferroni, DV Dependent variable, ACE Angiotensin converting enzyme, AS ankylosing spondylitis, BD behcet’s disease,
TB presumed latent tuberculosis, P. Sarcoidosis presumed sarcoidosis, P. Syphilis presumed latent syphilis
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to induce the recruitment of activated T helper (Th1)
cells [16, 17]. Serum levels of CXCL9 and CXCL10 have
been correlated with serum ACE levels in presumed
ocular sarcoidosis [15]. Interleukin 12 (IL-12) p40, an
essential component of IL-12 has been reported to in-
duce differentiation of naïve Th cells into Th1 cells [15].
Serum concentrations of IL-12 p40 have been found sig-
nificantly higher in pulmonary sarcoidosis than healthy
subjects and have been correlated with serum levels of
ACE and lysozyme [18]. This study compares for the
first time the serum ACE and lysozyme levels of patients
diagnosed with ocular involvement of autoimmune dis-
eases such as AS, BD and presumed sarcoidosis and
ocular involvement of infectious diseases such as pre-
sumed latent TB and presumed latent syphilis. Intraocu-
lar inflammation compatible with sarcoidosis associated
with elevated serum ACE levels is considered suggestive
for diagnosis of presumptive sarcoidosis in patients with-
out having a tissue biopsy [16, 17, 19–21]. The serum
ACE level is disclosed higher in children than in adults
[21]. The World Association of Sarcoidosis and Other
Granulomatous disorders (WASOG) considered an in-
creased ACE might help in diagnosis of sarcoidosis in
children [22]. The age range in sarcoidosis group in our
study is between 10 and 72 with a mean age of 41. The
estimated mean level of serum ACE of our patients with
Table 5 Pairwise comparison of the mean difference values of serum lysozyme levels of the patients with ocular involvement of
ankylosing spondylitis, behcet’s disease, presumed sarcoidosis, presumed latent tuberculosis, presumed latent syphilis and control group
Pairwise Comparison Mean Difference Standard Deviation Sig.b 95 % CI Lower Bound 95 % CI Upper Bound
AS - BD −0.247 1.033 1.000 −3.306 2.812
AS - P. Sarcoidosis −6.641 1.334 0.0001 −10.590 −2.691
AS - TB −0.863 1.085 1.000 −4.075 2.349
AS - P. Syphilis 0.144 2.020 1.000 −5.837 6.124
AS - Control 0.928 1.531 1.000 −3.607 5.462
BD - AS 0.247 1.033 1.000 −2.812 3.306
BD – P. Sarcoidosis −6.394 1.346 0.0001 −10.380 −2.408
BD - TB −0.616 1.124 1.000 −3.945 2.713
BD - P. Syphilis 0.391 2.031 1.000 −5.625 6.407
BD - Control 1.175 1.530 1.000 −3.356 5.705
P. Sarcoidosis - AS 6.641 1.334 0.0001 2.691 10.590
P. Sarcoidosis - BD 6.394 1.346 0.0001 2.408 10.380
P. Sarcoidosis - TB 5.778 1.392 0.001 1.656 9.900
P. Sarcoidosis–P. Syphilis 6.785 2.198 0.033 0.277 13.293
P. Sarcoidosis – Control 7.568 1.756 0.0001 2.369 12.768
TB - AS 0.863 1.085 1.000 −2.349 4.075
TB - BD 0.616 1.124 1.000 −2.713 3.945
TB - P. Sarcoidosis −5.778 1.392 0.001 −9.900 −1.656
TB - P. Syphilis 1.007 2.047 1.000 −5.056 7.069
TB - Control 1.790 1.617 1.000 −2.997 6.578
P. Syphilis - AS −0.144 2.020 1.000 −6.124 5.837
P. Syphilis - BD −0.391 2.031 1.000 −6.407 5.625
P. Syphilis – P. Sarcoidosis −6.785 2.198 0.033 −13.293 −0.277
P. Syphilis - TB −1.007 2.047 1.000 −7.069 5.056
P. Syphilis - Control 0.784 2.328 1.000 −6.110 7.678
Control - AS −0.928 1.531 1.000 −5.462 3.607
Control - BD −1.175 1.530 1.000 −5.705 3.356
Control – P. Sarcoidosis −7.568 1.756 0.0001 −12.768 −2.369
Control - TB −1.790 1.617 1.000 −6.578 2.997
Control - P. Syphilis −0.784 2.328 1.000 −7.678 6.110
The mean difference is significant at the 0.05 level
Sigb Adjustment for multiple comparisons Bonferroni, CI Confidence Interval, ACE Angiotensin converting enzyme, AS ankylosing spondylitis, BD behcet’s disease,
TB presumed latent tuberculosis, P. Sarcoidosis presumed sarcoidosis, P. Syphilis presumed latent syphilis
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presumed sarcoidosis is 58.274 IU/L which is above the
normal adult range of 8–52 IU/L. Serum ACE level has
been compared between patients having sarcoidosis and
sarcoidosis-like lung diseases including TB, fibrosing
alveolitis, histiocytosis X, and pneumoconiosis [23]. Rise
of serum ACE activity has been found in 93 % of
patients with active sarcoidosis, 41 % of patients with TB
and 56 % of patients with nonspecific inflammatory lung
diseases including fibrosing alveolitis, histiocytosis X,
and pneumoconiosis [23]. Serum ACE level has not been
studied before in the ocular involvement of presumed
latent TB. Our study revealed the estimated marginal
mean of serum ACE level in patients with presumed
latent TB as 32.500 U/L. Pairwise comparison of serum
ACE levels between patients with presumed latent TB
and presumed sarcoidosis disclosed a statistically signifi-
cant difference for patients with presumed sarcoidosis
with respect to presumed latent TB (p = 0.0001). There
was also no significant difference of elevated serum ACE
levels between patients with presumed latent TB and
control group (p = 0.204).
The serum activity of ACE has been compared for
patients with BD, Vogt-Koyanagi-Harada’s disease and
sarcoidosis [24]. Significant elevation of serum ACE
activity has been observed only for patients with sarcoid-
osis [24]. Our study revealed the estimated marginal mean
of serum ACE level for patients with BD as 31.392 U/L. A
significant elevation of serum ACE level in patients with
presumed sarcoidosis with respect to BD has been dis-
closed in our study (p = 0.0001). Serum levels of ACE
activity have been compared in patients with rheumatoid
arthritis, osteoarthritis, ankylosing spondylitis, psoriatic
arthritis and BD, and no statistically significant differences
have been found from those of normal controls [25]. The
serum ACE activity has not been investigated in HLAB27
positive AS related uveitis. Our study disclosed the esti-
mated marginal mean of serum ACE level in patients with
AS as 29.363 U/L. Our study revealed a statistically signifi-
cant difference in serum ACE level for patients with pre-
sumed sarcoidosis compared to patients with AS (p =
0.0001). No significant difference of elevated serum ACE
levels was found between AS and control group. (p =
1.000) Elevated serum lysozyme levels have been included
in the criteria for diagnosis of ocular sarcoidosis [26]. The
serum levels of ACE and lysozyme have been reported
increased in 40 and 42 % of patients with biopsy-proven
ocular sarcoidosis respectively [27]. The levels of at least
one of the serum markers ACE and lysozyme were found
elevated in 58 % of patients with biopsy-proven sarcoid-
osis [27]. The estimated marginal means of serum ACE
and lysozyme levels for the patients with AS, BD, pre-
sumed sarcoidosis, presumed latent TB, presumed latent
syphilis and control group disclosed on Graph 1 and
Graph 2 in our study have similar curves with minimum
values for control group and maximum values for pre-
sumed sarcoidosis. The sensitivity of serum lysozyme for
predicting sarcoidosis was reported as 79.1 % and the
sensitivity of serum ACE for predicting sarcoidosis was
reported as 59 % [28]. However, the specificity of serum
lysozyme level has been reported to be less for sarcoidosis
than serum ACE level, and it has been considered that the
diagnostic value of serum lysozyme for sarcoidosis might
be limited [28]. In another study considering the predict-
ive value of serum ACE and lysozyme levels in diagnosis
of ocular sarcoidosis, the sensitivity of increased serum
ACE level was found as 84 %, specificity was 95 %, and
predictivity was 47 %. However, the sensitivity of increased
serum lysozyme levels was 60 %, specificity was 76 %, and
spredictivity was 12 % [29]. Both studies showed that
increased serum lysozyme levels might be less predictive
for ocular sarcoidosis. Our study revealed the estimated
marginal means of serum lysozyme for patients with AS,
BD, presumed sarcoidosis, presumed latent TB, presumed
latent syphilis and control group as 14.124, 14.371,
20.765,14.987, 13.980, and 13.196 mg/L respectively.
Pairwise comparisons of the serum lysozyme levels
between patients with presumed sarcoidosis and AS
and BD revealed statistically significant differences for pre-
sumed sarcoidosis (p = 0.0001 and p = 0.0001 respectively).
Pairwise comparison of the serum lysozyme levels be-
tween patients with presumed sarcoidosis and presumed
latent TB revealed a statistically significant difference for
sarcoidosis with the p value 0.001 which was greater than
the p value of pairwise comparison of the serum ACE
levels between patients with presumed sarcoidosis and
presumed latent TB. Pairwise comparison of the serum
lysozyme levels between the patients with presumed
sarcoidosis and presumed latent syphilis revealed a statis-
tically significant difference for presumed sarcoidosis with
the p value 0.033 which was also greater than the p value
of pairwise comparison of the serum ACE levels between
patients with presumed sarcoidosis and presumed latent
syphilis. Our study disclosed that increase in serum lyso-
zyme levels is more significant than increase in serum
ACE levels for patients with infectious uveitis such as pre-
sumed latent TB and presumed latent syphilis. This study
also revealed that the increase in serum lysozyme levels is
less specific than increase in serum ACE levels for pre-
sumed sarcoidosis, and elevated serum lysozyme levels
might be much more commonly detected in infectious
uveitis such as presumed latent TB and presumed latent
syphilis than autoimmune uveitis such as AS and BD.
Conclusions
Elevated serum ACE levels are significant for patients
with presumed sarcoidosis compared to ocular involve-
ment of other autoimmune diseases such as BD and AS,
and ocular involvement of infectious diseases such as
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presumed latent TB and presumed latent syphilis. How-
ever, elevated serum lysozyme levels might be also de-
tected in ocular involvement of infectious diseases such
as presumed latent TB and presumed latent syphilis.
Abbreviations
ACE: angiotensin converting enzyme; AS: ankylosing spondylitis; BD: behcet’s
disease; CI: confidence interval; CSF: cerebrospinal fluid; CXCL: chemokine;
D: dilution of the serum. ACE activity is given in units where 1 U is equivalent to
the cleavage of 1 μmol of FAPGG in 1 min; FAPGG: N-[3-(2-furyl) acryloyl]-L-
phenylalanyl-glycylglycine; FTAABS: fluorescent treponemal antibody absorption;
IP: interferon gamma-induced protein; k: change in optical density upon the
complete cleavage of 1 μmol of FAPGG; MHA-TP: microhemagglutination assay
for Treponema pallidum; RAS: renin angiotensin system; RPR: rapid plasma reagin;
S: rate of observed decrease in optical density; SD: standard deviation; Th: T
helper; VDRL: venereal disease research laboratory test; WASOG: World Association
of Sarcoidosis and Other Granulomatous disorders.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
OS carried out the clinical examinations, diagnosis, treatment and follow-up
the patients. AZ participated in design and coordination of the study. EK
carried out the statistical analysis of the study. NT carried out the biochemical
analysis of the sera of the patients and control groups. All authors have read
and approved the final version of the manuscript.
Acknowledgements
Reha Alpar, M.D. Professor of Biostatistics, Hacettepe University Medical
Faculty, for his contributions to the statistical evaluations of this study.
There is no fund supporting this study.
Author details
1Department of Ophthalmology/Uveitis, Dunya Goz Hospital Ltd., Ankara,
Turkey. 2Department of Ophthalmology, Boston University School of
Medicine, Boston, MA, USA. 3Department of Biostatistics, Hacettepe
University Medical Faculty, Ankara, Turkey. 4Department of Biochemistry,
Middle East Technical University, Health Sciences, Ankara, Turkey.
Received: 19 June 2015 Accepted: 9 February 2016
References
1. Chappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on
the Angiotensin Converting Enzyme 2-Angiotensin (1–7)-Mas Receptor Axis:
Fetal programming, sex differences, and intracellular pathways. Front
Endocrinol (Lausanne). 2014;4:201.
2. Miyazaki A, Kitaichi N, Ohgami K, Iwata D, Jin XH, Iwabuchi K, et al. Anti-
inflammatory effect of angiotensin type 1 receptor antagonist on
endotoxin-induced uveitis in rats. Graefes Arch Clin Exp Ophthalmol.
2008;246:747–57.
3. Kurihara T, Ozawa Y, Ishida S, Okano H, Tsubota K. Renin-Angiotensin system
hyperactivation can induce inflammation and retinal neural dysfunction. Int J
Inflam. 2012. doi:10.1155/2012/581695.
4. Bonfiolli AA, Orefice F. Sarcoidosis. Semin Ophthalmol. 2005;20:177–82.
5. Mulak M, Misiuk-Hojlo M, Slowik M. The behavior of angiotensin converting
enzyme in patients with uveitis. Klin Oczna. 1999;101:5–8.
6. Nash JA, Ballard TN, Weaver TE, Akinbi HT. The peptidoglycan degrading property
of lysozyme is not required for bacteriocidal activity in vivo. J Immunol. 2006;177:
519–26.
7. Majcherczyk PA, Langen H, Heumann M, Fountoulakis M, Glauser P, Moreillion P.
Digestion of Streptococcus pneumonia cell walls with its major peptidoglycan
hydrolase releases branched stem peptides carrying proinflammatory activity.
J Biol Chem. 1999;274:12537–43.
8. Sen DK, Sarin GS. Immunoassay of serum muramidase (lysozyme) in ocular
diseases. Indian J Ophthalmol. 1987;35:103–7.
9. Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First
International Workshop on ocular sarcoidosis. International criteria for the
diagnosis of ocular sarcoidosis: results of the first ınternational Workshop on
ocular sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160–9.
10. [No authors listed] Evaluation of the diagnostic (‘classification’) criteria in
Behcet’s disease-towards internationally agreed criteria. The International
Study Group for Behcet’s disease. Br J Rheumatol 1992;31:299–308.
11. Morshed MG. Current trend on syphilis diagnosis: issues and challenges.
Adv Exp Med Biol. 2014;808:51–64.
12. Beneteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC. Automated
kinetic assay of angiotensin-converting enzyme in serum. Clin Chem. 1986;
32:884–6.
13. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of
antigens by single radial immunodiffusion. Immunochemistry. 1965;2:235–54.
14. Takeuchi M, Oh-I K, Suzuki J, Hattori D, Takeuchi A, Okunuki Y, et al. Elevated
serum levels of CXCL9/monokine induced by interferon- Gamma and
CXCL10/interferon gamma-inducible protein-10 in ocular sarcoidosis. Invest
Ophthalmol Vis Sci. 2006;47:1063–8.
15. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells
with immunoregulatory functions in the generation of T-helper cells type 1
and cytotoxic lymphocytes. Blood. 1994;84:4008–27.
16. Murdoch C, Finn A. Chemokine receptors and their role in inflammation
and infectious diseases. Blood. 2000;95:3032–43.
17. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108–15.
18. Ichimura S et al. Increased circulating interleukin-12 (IL-12) p40 in
pulmonary sarcoidosis. Clin Exp Immunol. 2003;132:152–7.
19. Stavrou P, Linton S, Young DW, Murray PI. Clinical diagnosis of ocular sarcoidosis.
Eye (Lond). 1997;11:365–70.
20. Weinreb RN, O’Donnell JJ, Sandman R, Char DH, Kimura SJ. Angiotensin-
converting enzyme in sarcoid uveitis. Invest Ophthalmol Vis Sci. 1979;18:1285–7.
21. Power WJ, Neves RA, Rodriquez A, Pedrosa-Seres M, Foster CS. The value of
combined serum angiotensin-converting enzyme and gallium scan in
diagnosing ocular sarcoidosis. Ophthalmology. 1995;102:2007–11.
22. Deverriere G, Flamans-Klein A, Firmin D, Azouzi O, Courville P, Le Roux P.
Early onset pediatric sarcoidosis, diagnostic problems. Arch Pediatr. 2012;19:
707–10.
23. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R,
et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse
Lung Dis. 1999;16:149–73.
24. Adamovich VN, Borisov SE, Zubkov AA, Danilov SM, Sakharov II, Atochina
EN. Serum angiotensin converting enzyme in the diagnosis of sarcoidosis
and other lung diseases. Probl Tuberk. 1991;10:18–22.
25. Fukami R, Ohba S, Ishida K, Nakamura S, Konno M, Ohno S. Serum adenosine
deaminase and angiotensin converting enzyme activity in patients with
endogenous uveitis. Nihon Ganka Gakkai Zasshi. 1994;98:287–92.
26. Lowe JR, Dixon JS, Guthrie JA, McWhinney P. Serum and synovial fluid
levels of angiotensin converting enzyme in polyarthritis. Ann Rheum Dis.
1986;45:921–4.
27. Tomita H, Sato S, Matsuda R, Suquira R, Kawaquichi H, Niimi T, et al. Serum
lysozyme levels and clinical features of sarcoidosis. Lung. 1999;177:161–7.
28. Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical
features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch
Ophthalmol. 2011;129:409–13.
29. Baarsma GS, La Hey E, Glasius E, de Vries J, Kijlstra A. The predictive value of
serum angiotensin converting enzyme and lysozyme levels in the diagnosis
of ocular sarcoidosis. Am J Ophthalmol. 1987;104:211–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Sahin et al. BMC Ophthalmology  (2016) 16:19 Page 9 of 9
